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1. Invited essay
The world is presently grappling with a global pandemic known as
coronavirus (i.e., COVID-19; Guan et al., 2020). At the time of this
writing, 18.6 million confirmed cases and over 700,000 deaths due to
COVID-19 have been reported globally (Sun, Chen, & Viboud, 2020).
Although most individuals infected with COVID-19 present with
minimal symptoms, 15–20% of those who contract the disease experience severe symptoms that require medical intervention and hospitalizations (Guan et al., 2020; W. Liu et al., 2020; Olds & Kabbani, 2020;
Sun, Chen, & Viboud, 2020). Select segments of the population are at
greater risk for more severe COVID-19 symptoms, including older
persons and those with underlying medical conditions (e.g., heart disease, diabetes, liver disease, chronic lung disease, and being immunocompromised; Jiang, Zhou, & Tang, 2020; W. Liu et al., 2020;
Shiau, Krause, Valera, Swaminathan, & Halkitis, 2020; J. Zhang, Yang,
et al., 2020). At the present time there is no treatment or vaccine for
COVID-19 and many parts of the world, including the United States

∗

(U.S.), continue to experience daily increases in cases and deaths.
The pandemic has affected the world in a deep and far reaching
manner across nearly every level of analysis, ranging from personal
(e.g., death, developing a COVID-19 illness, elevated poor mental
health) to economic (e.g., economic recession, financial insecurity,
bankruptcy) to social (e.g., isolation, inability to attend work or school,
loss of developmental milestones such as graduation) (Guo et al., 2020;
Yao, Chen, & Xu, 2020; Zhou et al., 2020). The psychological and
lifestyle adjustment needed to cope with COVID-19 has offered a significant obstacle for many families and individuals. For example, many
caregivers have had to balance working at home with the additional
responsibility of homeschooling their children. Additionally, the stressrelated burden of COVID-19 has negatively impacted interpersonal relationships (e.g., conflict with a partner, domestic violence) due to close
living circumstances, social restriction, and heightened worries. These
pandemic-related issues sit in the larger context of the lack of information about the ‘true’ nature of COVID-19 (i.e., its etiology; Guan
et al., 2020) and misinformation across media and social outlets.
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COVID-19 has not affected all persons equally and many vulnerable
subgroups are differentially exposed to risks. For example, racial/ethnic
minority groups, individuals who are homeless, incarcerated or detained (e.g., immigration detention centers), or live-in poverty-stricken
environments are particularly susceptible to COVID-19 related problems even when not directly infected (Bhopal, 2020; Rimmer, 2020;
Yancy, 2020).
Governments around the world, including state and local constituents, are attempting to respond to the pandemic via various measures, ranging from the implementation of social distancing protocols,
initiation of efforts to rapidly develop an efficacious COVID-19 vaccine,
use of protective gear (e.g., face masks), public health messaging (e.g.,
how to wash hands properly to remove virus potential), restricting
travel, closing borders, and shutting down major parts of the economy,
among other tactics (Hale, Petherick, Phillips, & Webster, 2020, p. 31;
Paterlini, 2020). Many governments have had to issue emergency declarations and offer some form of immediate financial assistance to
businesses and families.
Many countries and some U.S. states are opening some aspect up
their economies following relative success of social distancing. From
countries to state and local municipalities, ‘opening up’ can involve
different strategies (e.g., staggering the opening of businesses and
schools) and mean different things (e.g., availability of medical supplies
and COVID-19 testing capabilities, sanitation protocols), creating the
potential for wide-spread confusion. During this time, there simultaneously remains a serious concern about the onslaught of future pandemic waves and the lack of an effective treatment for COVID-19. The
uncontrollability and unpredictability related to COVID-19 and its
health, social, and economic consequences is apt to elicit acute stress
and continued worry about what the future may hold for individuals,
families, communities, businesses, and countries (C. Wang, Luo, Chen,
Chen, & Li, 2020). In many respects, the COVID-19 pandemic serves as
a broad-based stressor and may interact with diatheses represented at
the individual, familial, community, and population level. Behavioral
scientists play an integral role in the acute and longer-term management of negative psychological, addictive, and health behavior consequences associated with the COVID-19 pandemic. Indeed, behavioral
scientists currently are and will continue to work with public health,
medicine, and governmental bodies to manage the psychological, addictive behavior, and health behavior aftermath of COVID-19 for youth,
adults, and older adults. These activities include direct assessment and
clinical care as well as policy-level actions. Like the work of other allied
disciplines (e.g., public health, medicine, social work), behavioral scientists help determine the short- and longer-term impact of COVID-19
and play an integral role in shaping how we – as a global community –
respond to the most certain risk of future pandemics.
The aim of this invited article in Behaviour Research and Therapy is to
offer a conceptual essay that discusses the psychological, addictive, and
health behavior correlates/issues related to the COVID-19 pandemic
from a behavioral science perspective. The limited empirical study of
psychologically-based behavioral outcomes associated with COVID-19
lends to the current essay necessarily maintaining a commentary
function, but with the clear objective of detailing the scientifically informed implications for mental health, addiction, and health behavior;
many of which will have ‘downstream’ effects. We have organized the
article around some of the most clinically important psychological
disorders, addictive behaviors, and health behaviors for well-being.
In the first section, we describe the COVID-19 implications for
mental health focusing on (a) anxiety/stress and mood disturbance, (b)
obsessive compulsive symptoms and disorders, and (c) posttraumatic
stress. Such mental health problems, although certainly not exhaustive
of the scope of psychological disorders impacted by COVID-19, are
some of the most common mental health issues in the general population and are frequently comorbid with chronic illness. In the second
section, we focus on addictive behaviors, including (d) tobacco (combustible and electronic), (e) alcohol use and misuse, and (e) cannabis.

These forms of drug use represent the most prevalent types of substance
use and are frequently associated with chronic illness and premature
death. In the third section, we spotlight health behavior and chronic
illness by discussing the role of (f) sleep health and behavior, (g)
chronic illness using the example of HIV/AIDS as an illustrative model,
and (h) physical activity. Health behaviors represent vital targets for
the mitigation of COVID-related disease and may play a key role in
psychological adjustment and recovery. In the final section, we highlight sociocultural factors (e.g., race/ethnicity, economic adversity),
developmental considerations, and the role of individual difference
factors for psychological, addictive, and health behavior and chronic
illness. We conclude by offering an integrative COVID-19 stress-based
model that could be used to guide research focused on the stress-related
burden of the pandemic.
2. Section one
2.1. Anxiety, stress, and mood
Fear is an adaptive defense mechanism that is fundamental for
survival and involves several psychological and biological processes of
preparation for a response to potentially threatening events. COVID-19
represents a true threat, with many unknowns. If you are infected, there
is a chance you could die, regardless of your current age, sex, or health
status. As such, fear is a natural and adaptive response to this pandemic.
On the other hand, every year tens of thousands die from influenza as
well as many other preventable or unexpected causes. This raises the
key question regarding the degree to which we should be anxious and
fearful of COVID-19. How much anxiety is reasonable? Since even basic
knowledge about COVID-19 is undeveloped, it will be difficult to
clearly discriminate between normal, adaptive fear responses and less
adaptive responses. That said, such an overarching true threat and the
concomitant stressors such as social isolation, economic uncertainty
and so forth could in fact recalibrate what is considered a normal level
of anxiety in the general population. Research has demonstrated that
trait levels of anxiety have increased in the US in recent decades,
though the cause of such increases is unknown (Twenge, 2000). The
COVID-19 pandemic is likely to contribute to these basic levels of trait
anxiety, thus creating a “new normal” level of anxiety.
If we consider the likely general increase in anxiety and stress in the
context of diathesis-stress conceptualizations of mental illness, we expect that such a salient and broad reaching stressor to increase the
incidence of pathological anxiety. Anxiety conditions are already highly
prevalent (Bandelow & Michaelis, 2015), and we may see an increased
incidence of anxiety psychopathology if the pandemic serves to push
vulnerable individuals toward the expression of maladaptive levels of
anxiety. Moreover, those with preexisting conditions are likely to have
their symptoms intensify. One could further speculate that forms of
pathological anxiety will increase. First responders and hospital personnel, particularly in affected areas are already showing troubling
signs of stress and psychopathology (Joob & Wiwanitkit, 2020). It is
highly likely that we will see increased rates of generalized anxiety and
posttraumatic stress related to the pandemic and its sequelae.
Beyond the somewhat vague notion of COVID-19 acting as a stressor
to increase both normal and pathological anxiety, it is interesting to
consider the specific mechanisms that play a role in this process. There
are several well-established parameters that relate to the genesis and
maintenance of anxiety that seem highly relevant to the current situation. These processes include perceptions relating to predictability/
certainty and controllability of threat (Barlow, 2004). Coming across a
shark while swimming is quite different from viewing the same shark in
an aquarium since a potential threat in the wild is far less predictable or
controllable than one in an enclosure. Historically, epidemics and
pandemics were considered divine punishments that were essentially
uncontrollable. Although medical understanding of pathogens has advanced, globalization now facilitates the spread of pathological agents,
2
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which diminishes the degree to which we can control them. Similarly,
naturally occurring mutations and adaptation of viruses ensure that
novel pathogens like COVID-19 will emerge and spread. These conditions leave us in a state of uncertainty, except that we can be certain
that COVID-19 and other infectious agents will persist. Thus, COVID-19
affects many of the core anxiety generating mechanisms since it leads to
a sense of diminished predictability and controllability along with increased uncertainty relating to a true threat. Ultimately, the COVID-19
pandemic creates an ideal environment for the onset, maintenance, and
exacerbation of anxiety symptoms and syndromes.

the pandemic (Alisic et al., 2014; Kilpatrick et al., 2013). A relative
minority, the proportions of which are unknown, may emerge from the
crisis with clinical or subclinical PTSD or with exacerbation in pre-existing PTSD symptoms and related mental health conditions (e.g., depression, substance use disorder). Women are at heightened risk of
PTSD following potentially traumatic events (Gaffey et al., 2019; Rattel
et al., 2019) and racial/ethnic minority populations may be especially
impacted due to socioeconomic inequities and health-related disparities
with regard to financial security and access to healthcare and treatment
(Asnaani & Hall-Clark, 2017; Cross et al., 2018; Sibrava et al., 2019).
The intersections of trauma and the COVID-19 pandemic are complex. Many constellations of interweaving risk and protective factors,
learning histories, and life circumstances can affect how trauma histories and potentially traumatic experiences during the COVID-19 crisis
can affect individual journeys of recovery. For example, more unbalanced, negative individual interpretations of the COVID-19 crisis
and related changes in beliefs about oneself, others, or the world may
have lasting deleterious effects (e.g., “I am damaged”; “People cannot
be trusted”; “The world is dangerous and unsafe”; Beierl, Böllinghaus,
Clark, Glucksman, & Ehlers, 2019; Bernardi & Jobson, 2019; Köhler,
Goebel, & Pedersen, 2019; LoSavio, Dillon, & Resick, 2017; Scher,
Suvak, & Resick, 2017). Similarly, avoidance of thoughts or emotions
related to the COVID-19 crisis may increase the risk of developing PTSD
symptoms and/or exacerbating or maintaining pre-existing trauma-related symptoms (e.g., Orcutt, Reffi, & Ellis, 2020, pp. 409–436). Additional risk factors for the development or exacerbation of PTSD symptoms
include a prior history of trauma or mental health disturbances, depressed or anxious mood, significant concurrent life stressors (e.g., financial problems, job loss, relationship stress), low social connectedness or support, sleep disturbance, substance use, and emotional
numbing or detachment (Colvonen, Straus, Acheson, & Gehrman, 2019;
Cusack et al., 2019; Germain, McKeon, & Campbell, 2017; Hancock &
Bryant, 2018; Shalev et al., 2019; Steenkamp et al., 2017; Vujanovic &
Back, 2019). Navigating the COVID-19 crisis requires a tolerance of
uncertainty that is challenging for all, but especially trauma survivors
who may have endured, sometimes over months or years (e.g., combat,
childhood abuse), unfathomable circumstances that were, by definition,
unpredictable and uncontrollable (e.g., Raines, Oglesby, Walton, True,
& Franklin, 2019; Vujanovic & Zegel, 2020). Undoubtedly, social connection and a sense of community and collectivism, hope, psychological
awareness, and healthy coping will differentiate risk versus resilience
trajectories during and after this crisis (Bernardi & Jobson, 2019; Long
& Gallagher, 2018, pp. 233–242; Thompson, Fiorillo, Rothbaum,
Ressler, & Michopoulos, 2018). Learning who suffers long-term negative
effects of the COVID-19 pandemic, why, and under what circumstances
will help us to understand how to intervene most effectively to psychologically support trauma survivors in the aftermath of this and future societal crises.
Indeed, reactions of trauma survivors to the COVID-19 crisis are also
likely to be as diverse as the traumas and individuals themselves with
the possibility of emergent themes. Theoretically, individuals with
histories of being directly impacted by natural disasters, people recovering from severe medical conditions, and those with histories of
imprisonment or captivity may feel especially emotionally reactive to
the large community-level impact, the social distancing and quarantining aspects of weathering COVID-19, and the continual perceived
health threat inherent to the pandemic. Individuals with interpersonal
trauma histories may experience a solidification or exacerbation of
maladaptive beliefs relevant to trust, safety, or power. Others may feel
increased social detachment or engage in increased harmful, self-injurious, or suicidal behaviors, particularly those with mood or substance use disorders. For some trauma survivors, following social distancing and self-quarantine guidelines may lead to less frequent
exposure to trauma-related reminders in the outside world and/or a
lower perceived interpersonal threat due to social-isolation, but increased trauma-related avoidance during the COVID-19 crisis in turn

2.2. Trauma and posttraumatic stress
The DSM-5 posttraumatic stress disorder (PTSD) Criterion A
(American Psychiatric Association [APA], 2013, p.271) defines trauma
as “exposure to actual or threatened death.” Individuals who are closer
to that exposure – providing healthcare to those infected, witnessing the
deleterious and perhaps deadly effects of the virus on patients or loved
ones, enduring losses of patients, family, or friends – might experience
the crisis as potentially traumatic. People on the frontlines of the pandemic, including healthcare personnel, first responders, grocery store
clerks, and other essential workers, encounter the threat of possible
exposure to the virus regularly and on an ongoing basis. Similarly, incarcerated populations and those who might feel compelled, financially
or otherwise, to work in close quarters without adequate personal
protective equipment (e.g., factory workers) may be exposed to the
COVID-19 virus for extended periods without perceived or actual recourse and suffer negative mental health repercussions as a result.
COVID-19 survivors, particularly those who might have struggled
through various medical procedures and prolonged hospitalizations,
may emerge with unique or shared constellations of mental health reactions from risk to resilience. Additional high-risk groups include
healthcare professionals or first responders who may have experienced
significant moral injuries (Jinkerson, 2016; Joannou, Besemann, &
Kriellaars, 2017; Williamson, Stevelink, & Greenberg, 2018) as a result
of making unfathomable decisions on the job (e.g., providing admission
or ventilator access to one patient at the sacrifice of another).
Yet, in addition to considering direct impacts of the novel COVID-19
virus on our population, it is imperative to understand the secondary
potentially traumatic effects of the pandemic on individuals and communities. The combination of prolonged stress, close quarters, and selfisolation guidelines has increased risk of domestic violence, child abuse,
and substance use (Abramson, 2020; National Institute on Drug Abuse,
2020; Santhanam, 2020; Taub, 2020). Indeed, physical and sexual
violence may escalate without the regular societal checks provided by
employers, schools, and loved ones. Furthermore, such violence may
stem from and/or intensify more unbridled substance use (Carter et al.,
2020) emerging from a context where uncertainty and unpredictability
are high, practical stressors (e.g., unemployment, financial stress, food
insecurity) may be difficult to problem-solve, and social supports may
be distant. Furthermore, in this pandemic, issues of grief and loss are
inevitably interwoven with those of potential trauma. Spiritual and
emotional grief processes to honor and emotionally mourn the losses of
loved ones may be interrupted by this pandemic, potentially exacerbating or prolonging grief, traumatic bereavement, or PTSD reactions.
To understand the effects of COVID-19 on the mental health of those
who experience it as potentially traumatic, we need to recognize first
that the impacts of trauma may not be fully determined nor completely
recognizable until after the traumatic stressor has concluded. The
COVID-19 crisis is going to have a long, yet undetermined course, and
thus our ongoing reactions to it are dynamic but indicative of peritraumatic rather than post-traumatic coping (Bell, Boden, Horwood, &
Mulder, 2017; Lapid Pickman, Greene, & Gelkopf, 2017). Based upon
decades of research, we can expect the majority of the population, regardless of level of proximity to or interaction with COVID-19, to demonstrate resilience and to recover psychologically in the aftermath of
3
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may exacerbate PTSD symptoms in the long-term. A high-risk subset
may emerge who are slow or reluctant to heed public health guidelines
due to a reaction against efforts to control, an increased risk-taking
propensity, all-or-none thinking, or helplessness resulting from a history punctuated by traumatic, uncontrollable events. This may lead to
incessant attempts, by some, to attain perceived control via closely
monitoring news, stockpiling food, or supplies, and maintaining constant vigilance. For those affected by trauma prior to and/or during the
COVID-19 crisis, the current, chronically stressful global atmosphere
where uncertainty reigns may feel especially overwhelming. For others,
this crisis may foster growth and resilience as they endure and overcome a crisis of epic and unimaginable proportions.

requiring increased hygiene, it remains to be seen what happens when
risk levels decline. That is, do cleaning behaviors likewise decline or
remain at elevated states thereby impacting diagnosis rates? Assessment approaches should continue to capture obsessive-compulsive
symptoms that are impairing, distressing and excessive relative to
current risk levels and not count symptoms that reflect behaviors consistent with accepted public health standards.
There are also treatment implications. The gold standard psychological treatment for adult and childhood OCD is cognitive behavioral
therapy with exposure and response prevention (ERP; McGuire et al.,
2015; Olatunji, Davis, Powers, & Smits, 2013). This treatment involves
gradual exposure to triggers that evoke obsessive-compulsive symptoms
while refraining from completing rituals or other avoidance behaviors.
A core element to this treatment is that exposure to triggers involves
exposure to ‘ordinary’ levels of risk. COVID-19 understandably has
shaken what is perceived as ordinary; fortunately, adept therapists have
shifted their practice to utilize exposures that reflect this new normal
such as relying on imaginal exposures or exposures targeting rituals in
excess of public health agency recommendations. At the same time,
some clinicians have negative attitudes towards exposure (Meyer,
Farrell, Kemp, Blakey, & Deacon, 2014) which is related to reduced
practice of this core therapeutic technique (Farrell, Deacon, Kemp,
Dixon, & Sy, 2013). It will be critical to provide guidelines established
by expert ERP clinicians for how providers integrate realistic COVID-19
concerns into their ongoing practice, as well as that in the future. A
concerning possibility is that ERP treatment post-COVID-19 is diluted
by virtue of therapists not practicing exposures to the actual level of
risk.

2.3. Obsessive compulsive symptoms and disorders
Obsessive-compulsive disorder (OCD) is a common (1–2% incidence; (Nestadt, Bienvenu, Cai, Samuels, & Eaton, 1998; Ruscio,
Stein, Chiu, & Kessler, 2010), disabling mental health condition characterized by presence of obsessions and/or compulsions (American
Psychiatric Association, 2013; Markarian et al., 2010). Symptoms present in a heterogeneous fashion across a number of dimensions, including contamination/cleaning, taboo obsessions (i.e., sexual, aggressive content), symmetry/repeating/ordering, and checking (McKay
et al., 2006). Childhood onset occurs in over 50% of cases and symptoms run a chronic course without adequate intervention (Pinto,
Mancebo, Eisen, Pagano, & Rasmussen, 2006). Clinical presentation is
further characterized by frequent comorbidity (Stein et al., 2019) and
variable degrees of insight (Hamblin, Park, Wu, & Storch, 2017). The
COVID-19 pandemic is likely to have a number of effects on those with
OCD, as well as those at risk. This includes the potential for symptom
exacerbation and increased incidence of OCD cases, as well as having
implications for assessment and treatment post-COVID-19.
Patients with OCD commonly present with contamination obsessions and associated cleaning compulsions (Mataix-Cols, do RosarioCampos, & Leckman, 2005; Pinto et al., 2006). Some individuals with
contamination related OCD have reported that their symptoms have
worsened in light of public health recommendations for increased
cleaning behaviors (e.g., washing, wearing masks) and other safety
behaviors (e.g., social distancing, wearing masks), which may be difficult for some patients to maintain within recommended guidelines.
COVID-19 has become a feared outcome for many patients with contamination-related OCD similar to other what has been observed with
other infectious diseases (e.g., HIV). Outside of contamination-focused
symptomology, other obsessive-compulsive symptoms may be affected
such as harm obsessions whereby someone fears that they may have
unintentionally spread COVID-19. Stress has an established relationship
with worsened obsessive-compulsive symptoms (Adams et al., 2018;
Brander, Perez-Vigil, Larsson, & Mataix-Cols, 2016), and availability of
coping strategies is taxed for many; this may further impact OCD
symptom presentation as well as comorbidity patterns. Although systematic data have not been presented, clinical accounts support
symptom worsening for some affected individuals while, on balance,
many others have not experienced negative symptomatic change.
Beyond worsening of symptoms in those with OCD, there is the
possibility that there will be increased cases in the near future. This
may involve those with subclinical symptoms or other risk factors experiencing onset or worsening of symptoms. The behavioral cycle of
OCD/anxiety highlights the role of negative reinforcement in which
rituals/avoidance are reinforced by distress reduction and creating a
cognitive sense of control (i.e., not getting COVID-19 is due to compulsions; Rector, Wilde, & Richter, 2017). In this scenario, a person
with or at risk for OCD may engage in rituals/safety behaviors in response to obsessional distress which in turn reduces anxiety and is
perceived as reducing the risk. Reduction in distress may motivate
further safety behaviors which, for some at risk, could begin to exceed
recommended guidelines. While ordinary levels of risk have risen

3. Section two
3.1. Tobacco
Cigarette smoking remains the leading cause of preventable death
and disability globally. Smoking may confer worse COVID-19 outcomes
given extensive evidence for the negative impact of smoking on lung
health and respiratory function (Tonnesen, Marott, Nordestgaard,
Bojesen, & Lange, 2019). Indeed, emerging evidence has identified
smoking as a possible risk factor for adverse COVID-19 prognosis and
disease progression (Patanavanich & Glantz, 2020; Vardavas &
Nikitara, 2020). In the largest study of COVID-19 patients, 16.9% of
severely affected patience were current smokers relative to 11.8% of
non-severe patients (Guan et al., 2020). An inverse pattern emerged
with non-smokers such that a greater proportion of non-severe patients
identified as a non-smoker relative to severe patients. Moreover, 25.5%
of COVID-19 patients who either needed mechanical ventilation, were
admitted to an intensive care unit, or died from complications related to
the disease were current smokers relative to 11.8% of those not experiencing these outcomes. Similar disparities in COVID-19 severity
across smoking status have been observed in other samples (W. Liu
et al., 2020; J. Zhang, Yang, et al., 2020). Thus, these data, albeit
preliminary and limited by sample size, indicate that smoking is a risk
factor for COVID-19 progression (W. Liu et al., 2020).
Taking a biological perspective to understand why smokers are more
susceptible to severe COVID-19 symptoms, recent research has proposed that smoking and COVID-19 susceptibility and symptom severity
may be related to an upregulation of the angiotensin-converting enzyme-2 (ACE2) receptor (Brake et al., 2020). ACE2, a membrane-bound
aminopeptidase that plays a vital role in cardiovascular and immune
systems, is highly expressed in the heart and the lungs (Turner, Hiscox,
& Hooper, 2004; Wang, Luo, Chen, Chen, & Li, 2020). Studies have
established that ACE2 is a receptor for the COVID-19 virus (J. Wang,
Luo, et al., 2020), and greater ACE2 gene expression has been observed
in smokers compared to non-smokers (Brake et al., 2020; Cai, 2020;
Emami, Javanmardi, Pirbonyeh, & Akbari, 2020; Tian et al., 2020; Wan,
Shang, Graham, Baric, & Li, 2020; Xu et al., 2020; Zhao et al., 2020;
4
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Zhou et al., 2020). The upregulation in ACE2 creates an environment
that allows greater potential for COVID-19 to infect human cells among
smokers through more opportunity to bind to this receptor (Olds &
Kabbani, 2020; Zuluaga, Montoya-Giraldo, & Buendia, 2020). In part,
this biological mechanism may help explain observed sex differences in
COVID-19. Specifically, COVID-19 symptom severity and mortality
rates in China indicate worse outcomes for men than for women, where
52.1% of men and 2.7% of women are current smokers (Parascandola &
Xiao, 2019; Sun et al., 2020). It is possible that the elevated smoking
rates among men in China, and therefore greater upregulation in ACE2,
contributed to significant gender difference in COVID-19 incidence and
severity (J. Wang, Luo, et al., 2020).
In addition to combustible cigarette smoking, there also is growing
concern for the impact of electronic cigarette (e-cigarette) use on
COVID-19 infection and disease progression (Lewis, 2020). Although it
is believed that the worldwide distribution and adoption of e-cigarettes
has the potential to increase population-level vulnerability to respiratory infecting diseases (Olds & Kabbani, 2020), such as COVID-19,
no studies have assessed e-cigarette use among COVID-19 patients
(Farsalinos, Barbouni, & Niaura, 2020). Given evidence for the impact
of various e-cigarette formulations on lung health and functioning
(Viswam, Trotter, Burge, & Walters, 2018) as well as the fact that most
e-cigarette users are former or current combustible cigarette users
(Mirbolouk et al., 2018), it is possible that product use will critically
impact the course of COVID-19 among users. Additionally, similar to
combustible cigarette use, it has been theorized that e-cigarette use may
engage an upregulation in ACE2 that parallels that of combustible cigarette use and increases the likelihood of COVID-19 infection (Brake
et al., 2020). Further research on these products and their influence on
COVID-19 outcomes is urgently needed.
A final point to consider is the effect that the COVID-19 pandemic
itself has on smoking. One of the leading reasons for smoking is stress
management (Baker, Piper, McCarthy, Majeskie, & Fiore, 2004; Garey
et al., in pressGarey et al., ). The psychological effect of the current
global environment, characterized by feelings of fear, uncertainty,
isolation, and stress (Mertens, Gerritsen, Salemink, & Engelhard, 2020),
coupled with limited availability of adaptive coping tools due to regulations and consequences of COVID-19 (i.e., social distancing, financial hardship) likely increases the risk for smoking onset, increased
intensity, and relapse (Patwardhan, 2020; Stubbs et al., 2017). Smoking
initiation and severity, in turn, increase susceptibility for COVID-19 and
worse disease-related outcomes. Behavioral scientists must engage in
targeted efforts to support current smokers and former smokers in
achieving and maintaining cessation during this particularly challenging time. There are promising initial findings from smoking cessation
programs implemented in smokers managing other infectious disease
that may help guide some of these initiatives (O'Cleirigh et al., 2018).
As more is learned about COVID-19, it is imperative that health care
providers assess smoking (and e-cigarette) use status as well as relapse
potential among former users and provide appropriate education and
intervention to help mitigate the potential risk of this health behavior
on disease infection and course.

2010; Szabo & Mandrekar, 2009), it is germane to consider the role that
alcohol consumption, whether chronic or in acute response to the ongoing crisis, may have on contraction of the COVID-19 virus. In addition to the direct physiological impact of alcohol consumption on the
body, the disinhibiting properties of alcohol (Kumar et al., 2009; OscarBerman & Marinković, 2007) may put individuals at risk for other
risky/poor decisions (George, Rogers, & Duka, 2005). For example,
those under the influence of alcohol may be more likely to violate social
distance protocols, exhibit poor hand washing procedures, or refuse/
forget to wear a face covering in public, leading to potential exposure to
and/or spreading of the virus. Importantly, impulsivity has reciprocal
relationships with alcohol such that consumption increases impulsive
behaviors and individuals with greater trait impulsivity (mis)use alcohol to a greater extent (Dick et al., 2010).
Moreover, the effects of impulsivity on alcohol (mis)use can be
amplified by other factors, such as stress, to confer greater risk for alcohol (mis)use (Fox, Bergquist, Gu, & Sinha, 2010). It is well-documented that stress, both acute and chronic, is a trigger for alcohol (mis)
use (Becker, Lopez, & Doremus-Fitzwater, 2011; Blaine & Sinha, 2017).
The COVID-19 pandemic has brought about both acute (e.g., work
displacement, limited availability of cleaning supplies) and chronic
stress (e.g., financial difficulty, isolation) that likely will contribute to
alcohol (mis)use for coping. It also is reasonable to expect that alcohol
(mis)use will worsen during the crisis in response to the stress and
uncertainty. For example, during the 2008–2009 economic recession,
although there was a decrease in prevalence of alcohol use overall (i.e.,
increase in abstainers), there was an increase in prevalence of binge
drinking (Bor, Basu, Coutts, McKee, & Stuckler, 2013). This suggests
that there may be a realignment/concentration of problematic drinking
such that a greater segment of those who do consume alcohol may be
doing so in a maladaptive or harmful way.
Although sales to restaurants and events have reduced markedly
during the pandemic, sales of online and to-go alcohol have skyrocketed (Nielsen, 2020). Given shelter in place orders and limits on
socializing, it is possible that greater amounts of alcohol are being
consumed at home/solitarily relative to social contexts. Solitary
drinking can, in some circumstances, lead to greater alcohol consumption than social drinking (Kuendig & Kuntsche, 2012) and is associated with greater alcohol-related consequences overall
(Christiansen, Vik, & Jarchow, 2002). For many, the COVID-19 pandemic has led to significant social isolation with in-person socializing
virtually eliminated and many working from home (if at all). These
conditions may also exacerbate a common reason for alcohol-related
relapse: boredom (Levy, 2008). Without other adaptive ways to manage
stress, socialize, or simply occupy one's mind, it is possible that craving
for alcohol may intensify.
Finally, there are important treatment implications for alcohol (mis)
use during COVID-19. Individuals already report numerous barriers to
seeking drug/alcohol treatment (McGovern, Xie, Segal, Siembab, &
Drake, 2006). In the wake of the pandemic additional barriers may arise
such as the perception that one's treatment is not a priority during a ‘life
or death’ pandemic or not worth the risk of leaving one's home. Alternatively, for those seeking treatment, there may simply not be local
resources available or treatment facilities may have waitlists. Although
the use of telehealth services are growing in general (Dorsey & Topol,
2016), there is more work to be done, with specific considerations for
low-income individuals (e.g. recently unemployed) who may be reluctant to spend money on treatment, perceive treatment to be a luxury,
or not have technological resources or a private location to engage in
telehealth. Affordable computer-based treatments without the need for
a provider that focus on stress and alcohol use (Paulus, Gallagher,
Neighbors, & Zvolensky, 2020) could be particularly pertinent during
this pandemic.

3.2. Alcohol
The (mis)use of alcohol is a leading risk factor for global disease
burden and preventable death (Degenhardt et al., 2018; Organization,
2019). Alarmingly, alcohol use, high-risk drinking, alcohol use disorder
(AUD), and alcohol-related deaths were increasing before the COVID-19
pandemic (Grant et al., 2017; White, Castle, Hingson, & Powell, 2020).
Despite the widespread belief that moderate alcohol consumption may
confer health benefits (Diaz et al., 2002; Romeo et al., 2007), more
recent work suggests that any alcohol consumption is associated with
health risks (Griswold et al., 2018). In fact, given the immunosuppressing effects of alcohol both generally and in the respiratory system specifically (Molina, Happel, Zhang, Kolls, & Nelson,
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3.3. Cannabis

tar and gases (Tashkin & Roth, 2019). Further, respiratory symptoms
such as chronic cough, sputum, and airway mucosal inflammation are
also similar between cannabis smokers and tobacco smokers. The impact on respiratory functioning of cannabis smoke has led for the
consideration of cannabis use as a pre-exiting condition that could increase the likelihood of more severe complications should one contract
COVID-19 (National Institute on Drug Abuse, 2020).

Cannabis use rates continue to increase, with nearly 44 million individuals 12 years and older in the U.S. endorsing past year cannabis
use in 2018, a rate greater than the rate in every year since 2002
(Substance Abuse and Mental Health Services Administration Center for
Behavioral Health Statistics and Quality, 2019). Further, rates of cannabis use disorder (CUD) remain greater than rates of all other federally
illicit substance use disorders combined. Despite the high rates of CUD,
perceived risk of cannabis use continues to decline (Okaneku, Vearrier,
McKeever, LaSala, & Greenberg, 2015; Substance Abuse and Mental
Health Services Administration Center for Behavioral Health Statistics
and Quality, 2019) presumably due at least in part to legalization of
recreational and/or medical marijuana at the state level (Johnston,
O'Malley, Miech, Bachman, & Schulenberg, 2015). Notably, cannabis
users report using more cannabis during times of heightened distress
following national disasters such as the September 11, 2001 terrorist
attacks, a pattern that was especially prominent among individuals who
experienced post-traumatic stress disorder and depression (Vlahov
et al., 2002). It therefore follows that cannabis use and associated
problems may increase during the COVID-19 pandemic.
Cannabis use increases during times of distress to manage negative
affect. In support of this contention, cannabis users report relaxation
and tension relief as one of the most common reasons for use
(Copeland, Swift, & Rees, 2001; Hathaway, 2003; Reilly, Didcott, Swift,
& Hall, 1998). Data from experimental studies support these self-reports. To illustrate, current cannabis users were randomly assigned to
an anxiety-induction or non-anxious control condition and cannabis
craving increased from before to during the task among participants in
the anxiety condition, but not among those in the control condition
(Buckner, Ecker, & Vinci, 2013). These data indicate that cannabis users
were especially vulnerable to wanting to use cannabis during an anxiety-provoking situation, which has direct implications for the COVID19 pandemic characterized by heightened stress. Notably, this effect
was specific to cannabis craving and was not observed for craving for
alcohol or cigarettes in this sample of cannabis users. Coping motives
are the most common reasons cited for wanting to use during laboratory-induced anxiety (Buckner, Zvolensky, Ecker, & Jeffries, 2016).
Prospective data collected via ecological momentary assessment also
confirm that anxiety is positively, significantly related to cannabis
craving at the momentary level, and is related to greater subsequent
craving (Buckner, Crosby, Silgado, Wonderlich, & Schmidt, 2012).
Further, although positive and negative affect were greater immediately prior to cannabis use compared to non-use episode, negative
affect increased at a significant rate prior to cannabis use, and decreased at a significant rate following cannabis use; changes in positive
affect were not significantly related to use (Buckner et al., 2015).
Further, the stress associated with the COVID-19 pandemic may
serve as trigger for lapse and/or relapse among individuals undergoing
a cannabis quit attempt. In a qualitative interview following cannabis
quit attempts, situations involving negative affect and exposure to
others smoking cannabis were among the most difficult situations individuals reported in which to abstain (Hughes, Peters, Callas, Budney,
& Livingstone, 2008). Among cannabis users undoing a self-guided quit
attempt, data from ecological momentary analysis indicated that although positive and negative affect were significantly higher during
cannabis lapse episodes compared to non-use episodes, when negative
and positive affect were analyzed simultaneously, negative affect, but
not positive affect, remained significantly related to lapse (Buckner,
Zvolensky, & Ecker, 2013). Again, the most common reason for use
cited during lapse episodes was to cope with negative affect.
Not only could COVID-19 increase cannabis use, but cannabis use
may exacerbate COVID-19 symptoms given that smoking cannabis damages the lungs. Respiratory toxins (including carcinogens) in cannabis
smoke are similar to that of tobacco smoke but notably the smoking
topography for cannabis leads to higher per-puff exposures to inhaled

4. Section three
4.1. Sleep health and behavior
Sleep is a fundamentally restorative process, but it is also highly
responsive to stress (Irwin, 2015). During times of increased stress,
sleep, quite paradoxically, serves both as a major line of defense and as
a source of heightened vulnerability. These relationships derive from
the fact that sleep and immunological functioning are reciprocally related: sleep promotes healthy immune responses and healthy immune
responses (e.g., to infectious agents) promote deeper, more restorative
sleep (Opp, 2005). Precise mechanisms are of course complex, but
several specific links are noteworthy. Immune-signaling proteins called
cytokines, such as tumor necrosis factor (TNF) and interleukin-1 (IL-1)
directly target infection and inflammation but are also known to promote sleepiness and non-rapid eye movement (NREM) sleep (Jewett &
Krueger, 2012). The hormone melatonin, which provides an endogenous marker of circadian phase peaks during the nocturnal sleep
period but also has important immunomodulatory effects. Conversely,
the hypothalamus–pituitary–adrenal (HPA) axis and the sympathetic
nervous system (SNS), two primary stress response systems, are downregulated during sleep, decreasing immune-regulating cortisol levels
(Besedovsky, Lange, & Born, 2012). However, when sleep is inadequate
or disrupted, alteration in these systems is readily observable. Experimental sleep research provides overwhelming evidence for the detrimental effects of chronic sleep disruption on immune responses including increases in multiple inflammatory markers such as C-reactive
protein, diminished immune response to vaccination, and enhanced
susceptibility to bacteria and toxins (Besedovsky et al., 2012). Rather
than representing enhanced immunity, elevated levels of inflammation
are associated with a range of health risks including cardio-pulmonary
disease (Libby, 2006).
Sleep's inextricable role in human immunological functioning
clearly place it at the forefront of critical behaviors during a pandemic.
Unfortunately, multiple aspects of the COVID-19 pandemic threaten
healthy sleep patterns which in turn endanger both physical and mental
health. Widespread uncertainty, 24-h media coverage (including misinformation), fear for one's own health and the health of loved ones,
and potential loss of employment/wages are but a few of the significant
sources of stress present during these unprecedented times. Heighted
psychological and physiological arousal elicited by such stress falls in
direct odds with a calm, quiescent state necessary for sleep onset and
maintenance. Further, common behaviors aimed at managing increased
stress and anxiety such as smoking, alcohol consumption, and decreased physical activity can give rise to or worsen sleep disruption via
known negative effects on sleep duration and quality (Irish, Kline,
Gunn, Buysse, & Hall, 2015). Moreover, sleep deprivation can amplify
inflammatory responses (Bollinger, Bollinger, Oster, & Solbach, 2010),
increasing the risk for poor outcomes in COVID-19 as unrestrained inflammation is implicated in the pathophysiology of the disease
(Gamaldo, Shaikh, & McArthur, 2012).
Although predisposing (e.g., genetics) and precipitating (e.g.,
trauma) factors play a role, stress is considered a primary cause of insomnia (Morin, Rodrigue, & Ivers, 2003) and among insomniacs, perceived inability to sleep often becomes a major source of stress in its
own right. Studies that have systematically examined incidence and
severity of insomnia symptoms during a global pandemic are unavailable despite ubiquitous anecdotal reports and cautions from health
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professional regarding the immunosuppressive effects of poor sleep.
However, in a recently-published study conducted between January 29
and February 3, 2020, C. Zhang, Yang, et al. (2020) surveyed medical
staff responding to the COVID-19 pandemic in China using the Insomnia Severity Index (ISI; Morin, Belleville, Bélanger, & Ivers, 2011).
More than a third of workers (36.1%) endorsed symptoms indicative of
clinical insomnia and those with insomnia reported elevated levels of
depression. Insomnia is well-known to herald the onset of depression
both acutely and years later even among those who have never been
depressed (Baglioni et al., 2011). Studies directed at uncovering precise
mechanisms of affective risk during the COVID-19 pandemic must
therefore consider the presence and severity of insomnia symptoms.
The COVID-19 pandemic also has upended daily routines and associated ‘cues’ that serve to maintain regular sleep schedules. Working
from home, altered mealtimes, increased sedentary behavior, social
distancing, and increased “screen time” are only some of the changes
that hold potential to disrupt circadian rhythms that govern sleep-wake
patterns. Other factors such as social activities also can affect sleepwake patterns. The human internal circadian clock runs slightly longer
than 24 h and therefore needs to be ‘entrained’ to the 24-h day via
internal and external cues (Czeisler et al., 1999). Sunlight is the most
potent exogenous cue that aligns our internal rhythm to the external
environment, but quarantine measures and greater time spent indoors
means that many individuals are receiving inadequate dosages of light
exposure. Although public health guidelines center on sufficient sleep
duration (Watson et al., 2015), sleep timing is equally critical for
overall health and well-being. Misalignment of the sleep period with
the body's ‘biological night’ is routinely linked with a host of serious
risks, including anxiety, depression, suicide, cardiac events, and several
forms of cancer (Baron & Reid, 2014). Healthcare workers who are
working long hours and night shifts during the COVID-19 pandemic are
therefore a particularly high-risk group for circadian shifts and associated comorbidities. Considering sleep's role in immunological function, this represents an area of priority for future research.

of new HIV cases. HIV incidence rates in the U.S. are also significantly
higher for those who are homeless or living in poverty (Denning &
DiNenno, 2020).
With respect to individual barriers to care, PLWH are disproportionally affected by traumatic life experiences, anxiety, depression, and substance use (Brandt et al., 2017; Nanni, Caruso, Mitchell,
Meggiolaro, & Grassi, 2015; C. O’Cleirigh, Magidson, Skeer, Mayer, &
Safren, 2015). Each of these also have been associated with poorer
engagement in HIV care, worse antiretroviral medication adherence,
and poorer HIV disease course. Their co-occurrence and interaction
significantly increases both the risk for HIV infection (Mimiaga et al.,
2015) and poorer HIV disease management among those already infected (Harkness et al., 2018; Pantalone, Valentine, Woodward, &
O'Cleirigh, 2018). These mental health barriers to full engagement in
HIV care may well be exacerbated by increased levels of COVID-19
specific anxieties and increases in general health-related anxieties. The
requirements of social distancing also may contribute to feelings of
isolation and loneliness which may in turn contribute to increased depression or depression-related withdrawal. Both anxiety-related
avoidance and depressive related withdrawal will likely have negative
consequences for self-care generally and for HIV care specifically. These
increases in distress will occur at a time when access to behavioral
health services is already severely restricted. Some PLWH who become
co-infected with COVID-19 will already be struggling with HIV disease
management (e.g., missed medical appointments, sub-optimal medication adherence) and may require additional supports to manage COVID19 care and treatment at a time when many routine supports may not
be available due social distancing and lack of routine medical services.
Protecting access to care and treatment among those already
struggling with the complexities of the HIV care cascade who must now
manage the additional burdens of the COVID-19 illness is a robust
clinical concern. Here, we underline the importance of community
(Carrico et al., 2020) and health worker based approaches (Operario,
King, & Gamarel, 2020) to HIV treatment and protecting access to care
through innovative and virtual care models. Many of those at risk for
being lost to care during this COVID-19 pandemic also may be vulnerable to perceived stigma (Krier, Bozich, Pompa, & Friedman, 2020;
Logie, 2020). Many will have multiple stigmatized identities with respect to HIV status, COVID-19 status, substance use, sexual or gender
minority status, and others. Keeping our community members and
peers involved in our service delivery will help ensure our treatments
are delivered in stigma-free contexts. Empirical support for integrated
treatment platforms that address mental health (Ironson et al., 2013;
Safren, O'Cleirigh, Skeer, Elsesser, & Mayer, 2013) and substance use
issues (Mimiaga et al., 2019; Safren et al., 2012) to protect engagement
in HIV treatment and prevention (Mayer et al., 2017; Conall O’Cleirigh
et al., 2019) are available to guide these initiatives. In addition, protecting access and supporting engagement (virtual or otherwise), to
mental health and substance use treatment will be critically important.
These approaches may be particularly key for protecting access to HIV
prevention services (i.e., HIV testing, access to Preexposure Prophylaxis
[PrEP]) for those at risk for HIV. Access to these services may be particularly important for those whose behavioral risk profiles and risk
appraisals may be disturbed because of the impact of social distancing
on usual patterns of substance use or sexual behavior.

4.2. Chronic illness: using HIV/AIDS as an exemplar
The intersection of COVID-19 with pre-existing chronic medical
illness (e.g., cardiovascular disease, diabetes, HIV) raises additional
challenges to the patient for managing multiple treatment cascades.
These challenges are exacerbated by the poorer survival and disease
course for patients with underlying medical conditions (Emami et al.,
2020) which in turn seems to be driving, in part, the alarming COVID19 racial disparity (Laurencin & McClinton, 2020). The overlapping
epidemic of COVID-19 with HIV, for example, presents unique challenges for HIV access to care, HIV treatment engagement, and prevention.
At this time, it is not known whether HIV infection increases susceptibility to COVID-19 infection or if it exacerbates the likelihood of
poor COVID-19 outcomes. However, people living with HIV may have
other comorbidities, such as cardiovascular disease and chronic lung
disease, that increase the risk for a more severe course of COVID-19
illness (Guaraldi et al., 2011; Guo et al., 2020). There is also a concern
that individuals who are immunocompromised, such as those with HIV,
may be at greater risk for severe COVID-19 symptoms (CDC, 2020a;
Duffau et al., 2018).
In the U.S., most people living with HIV (PLWH) are tested, linked
to HIV care, well engaged in antiretroviral treatment, and achieve HIV
viral suppression thus ensuring their optimal health and protecting the
public health by containing onward transmission (CDC, 2020b). However, structural and individual barriers to treatment and prevention
create enduring inequalities and significantly increase the risk of infection, reduce access to, and engagement in, HIV care, and compromise participation in HIV biobehavioral prevention among particular
risk groups. Gay and bisexual men (particularly Hispanic and African
American men) are most impacted by HIV and account for nearly 70%

4.3. Physical activity
Although much remains unknown about COVID-19 and the mental
health consequences of the pandemic, it is likely that regular physical
activity offers protective effects. Regular physical activity reduces risk
of and helps manage conditions that appear to increase risk of adverse
outcomes of COVID-19 (e.g., obesity, cardiovascular disease, diabetes;
Lee et al., 2012), and improves immune function (Nieman & Wentz,
2019) which likely positively affects the progression of COVID-19. It
also buffers the effect of stressors and (in part thereby) can prevent the
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onset of mental health conditions (Harvey et al., 2018; Jacquart et al.,
2019). Further, diminished physical activity can disrupt sleep quality
(Buman & King, 2010; Youngstedt & Kline, 2006), which increases
susceptibility to infection and mental and physical illness (see Sleep
section). Hence, establishing or maintaining a regular physical activity
habit has the potential to mitigate the impact of the pandemic both at a
personal and societal level.
Establishing and maintaining a regular physical activity habit has
proven to be challenging. Indeed, only 24% of adults meet the guidelines set forth by the Department of Health and Human Services
(Whitfield et al., 2019). The COVID-19 pandemic has impacted several
factors, including a change in the daily routine and increased stress and
anxiety, that can affect the intent of or ability to engage in behavior
change. It is important to acknowledge the relationship between factors
such as stress or changes in routine and physical activity participation
can vary in strength or direction (i.e., negative or positive) depending
on the individual and their context. For example, for some routine
changes have created barriers for exercise participation, while for
others changes to the daily structure have opened opportunities to
engage in regular exercise. Similarly, stress and anxiety at the “right”
level can be motivating for some make exercise part of their daily
routine, but when stress and anxiety become overwhelming, automated
emotion action tendencies often cause people to move away from
healthy (coping) behaviors such as exercise (Otto et al., 2016). Importantly, such relationships may further vary within and across individuals depending on other individual difference variables (e.g., risk
factors, protective factors, [mental] health diagnosis) and contextual
factors (e.g., job loss, financial stress, isolation).
Research aimed at understanding the relationship between COVID19 and physical activity mostly likely will benefit from considering the
importance of individual differences and the influence of contextual
factors. Comprehensive assessment batteries and statistical models that
include the testing of these complex moderation effects are key. This
perspective that acknowledges nuance in the relationship between
COVID-19 (pandemic) and physical activity also will aid efforts to develop or fine-tune intervention programs for physical activity uptake.

adversity, and racial/ethnic factors as three prototypical factors of
public health importance.
First responders and healthcare professionals. Of all the sectors
of the population, first responders and front-line healthcare professionals are arguably at the greatest risk for at least acute disruptions in
anxiety, stress, and negative mood. First responders and healthcare
professionals at the front line of the COVID-19 pandemic have at their
core mission to protect and preserve life (Prati & Pietrantoni, 2010).
These groups, although engaging in a diverse range of specific occupational activities (e.g., direct medical care, transport, public safety
enforcement), share in common that they are among the first to respond
to the COVID-19 crisis and take primary responsibility for attending to
COVID-19 related health issues.
First responders and healthcare professionals are undoubtedly experiencing emotionally challenging and unpredictable situations that
can place their lives in danger. The acute emotional effects of managing
COVID-19 cases is likely to be amplified by heavy work schedules and
reduced access to and isolation from social support systems (e.g., selfisolation after finishing a shift). It is likely that first responders and
healthcare professionals working with COVID-19 cases in hospitals will
be exposed to potentially traumatic events, the greater-than-usual experience of life-threatening situations, working with emotional strain
related to isolation of patients from their families (e.g., compassion
stress in the form of offering emotional support to patients in a manner
that family or caregiver of patients would typically offer), and exposure
to the struggle to life and death. These experiences are apt to challenge
the coping resources of even the most seasoned professionals, which
can result in higher degrees of anxiety, stress, and depressed mood
(LaFauci Schutt & Marotta, 2011). Such elevated stress levels are likely
to be related to changes in cognition and physical health, including
emotional exhaustion, fatigue, sleep dysfunction, and problems with
interpersonal relationships (Kronenberg et al., 2008; Lane, Lating,
Lowry, & Martino, 2010). Cognitive-based beliefs about personal safety
and health can be altered and memories of potentially traumatic events
engrained (Setti & Argentero, 2014).
Collectively, the COVID-19 related stress burden, as discussed in
several sections of the current essay, will have a high likelihood of
being related to increased risk of anxiety and depression for first responders and medical professionals working at the front line. Moreover,
consistent with past literature of these populations, the regulation of
affect will be associated with addictive and health behavior to modulate
such affect (e.g., physical activity, substance use). Although some regulatory behavior will be adaptive (e.g., increasing sleep where possible
to aid in recovery, engaging in regular physical exercise), others may be
less adaptive (e.g., smoking to reduce stress) and promote the risk for
other health problems (e.g., physical illness).
Economic adversity. Economic hardship related to COVID-19 is
already evident at numerous levels of analysis, including job loss, reduced earnings, higher debt relative to assets ratio, inability to pay
mortgage and bills, meeting governmental guidelines for poverty status,
and worry about financials resources going forward due to the turbulent nature of the economy. Past work has shown that economic
hardship is related to behavioral health problems, including psychological disorders, addictive behavior, physical health problems, and interpersonal dysfunction in adults and children (K. J. Conger et al., 2012;
Sareen, Afifi, McMillan, & Asmundson, 2011). For instance, economic
adversity has been linked to reduced social competence and elevated
physiological markers of stress (K. E. Bolger, Patterson, Thompson, &
Kupersmidt, 1995; Evans & English, 2002). Further, economic hardship
is related to self-regulation capacity and the corresponding difficulty in
dealing with additional responsibilities. For example, past work has
found limited socioeconomic resources are related to harsher parenting
behavior and greater substance use (R. D. Conger & Donnellan, 2007).
The negative effects may be particularly profound when economic
hardship is severe or chronic (Dearing, McCartney, & Taylor, 2001;
Magnuson & Duncan, 2002). The totality of worsening economic

5. Section four
The COVID-19 pandemic, although still ongoing and presently
under investigated from a behavioral health perspective, is apt to impart acute and potentially chronic exacerbations in psychological
symptoms and disorders, addictive behavior, and health behavior and
chronic illness. Across various phenotypes overviewed in the current
essay, previous scientific work and theoretical models predict COVID19, regardless of acquisition of the virus, has and will continue to have a
strong negative psychological impact on negative mood states, various
forms of substance use, and sleep, chronic illness, and physical activity.
Although many of these relations would be expected, theoretically, to
be negative, select subgroups will certainly adaptively respond to
COVID-19 related stress (e.g., improve their physical fitness, improve
self-care routines, quit/reduce maladaptive behaviors that place them
at risk). In this final section of the paper, we discuss sociocultural
considerations, developmental issues, and the role of individual difference factors for COVID-19-related psychological, addictive, health
behavior and chronic illness. We conclude by offering an integrative
COVID-19 model that could be used to guide research focused on the
stress-related burden of the pandemic.
5.1. Sociocultural factors
Certain subpopulations and contextual factors (e.g., loss of work)
are likely to signify a vulnerability gradient for COVID-19 in terms of
mental health, addictive behavior, and health behavior. Although there
are numerous possible sociocultural factors that could be relevant, we
highlight first responders and medical professionals, economic
8
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conditions for individuals and families in the larger context of an uncertain economic future are apt to be related to elevations in anxiety,
stress, and depression as well as other negative emotional states (e.g.,
anger, frustration, fatigue; Newland, Crnic, Cox, & Mills-Koonce, 2013).
Such emotional symptoms and problems are likely to be related to
elevations in substance use and other maladaptive behavior (e.g., less
supportive interpersonal behavior, less affection) and may exacerbate
chronic health conditions. Other work has found that these processes
also disrupt social interconnections (Scaramella, Sohr-Preston,
Callahan, & Mirabile, 2008).
Primary care givers who have children home from school, are unlikely to be able to work at their full capacity even with added flexibility in schedules. Although certain occupations have decreased activity, many have not. Therefore, it could be expected that for
individuals with added responsibilities of educating their children at
home occupational stress may be greater compared to those without
such responsibilities. Further, it is possible that the accumulation of
occupational responsibilities that are not addressed for persons with
additional educational responsibilities will accumulate and make it
more challenging to recover when going back to ‘normal,’ resulting in a
greater degree of occupational stress.
Grappling with lower socioeconomic states related to COVID-19
will, for certain segments of the population, offer an additional psychological challenge. Indeed, past work has repeatedly documented
that lower socioeconomic status is related to adverse health outcomes
for chronic illness and mortality rates (Adler et al., 1994; Adler, Boyce,
Chesney, Folkman, & Syme, 1993). Moreover, harms faced by people
who cannot afford not to work in dangerous settings can exacerbate the
psychological and health risk associated with COID-19. Further essential workers are more apt to be persons of color (Handerson,
McCullough, & Treuhaft, 2020). Certain groups will be more likely to
recover than others, which past work indicates is related to poorer
health outcomes even at higher socioeconomic levels (Kraus, Borhani, &
Franti, 1980). Moreover, research has found that lower socioeconomic
persons experience more chronic stress and negative life events
(Stansfeld, North, White, & Marmot, 1995). Additionally, lower socioeconomic status is related to cognitive biases for threat (Chen &
Matthews, 2001), which engender greater degrees of interpersonal
conflict and heightened negative emotional states (Matthews et al.,
2000; Stansfeld, Head, & Marmot, 1997). It would be expected that
such negative emotional experiences will be related to maintained direct relations with poorer health behavior and health outcomes
(McEwen & Stellar, 1993). In fact, research has consistently found that
lower socioeconomic status is related to greater degrees of anxiety,
stress, and depression when compared to those higher in socioeconomic
status (McLeod & Kessler, 1990). This heightened stress reactivity may
be at least in part attributable to having fewer resources. Consequently,
those struggling with a lower socioeconomic status due to COVD-19
may be more contexts in which they must utilize their emotional resources and be less likely to be in a sociocultural context wherein such
resources can be replenished (Holahan, Moos, Holahan, & Cronkite,
1999). This perspective is in line with past work that has found that
when persons are exposed to chronic stress, emotional resources are
challenged, and there is a greater risk for future emotional distress (N.
Bolger & Zuckerman, 1995; Ensel & Lin, 1991).
Racial/ethnic considerations. There is broad band evidence that
significant health disparities exist for persons of racial/ethnic minority
in the U.S. and beyond prior to COVID-19 for psychological, addictive
behavior, and health behavior as well as chronic illness. For example,
African American/Black individuals experience a disproportionate
burden in disease morbidity, mortality, disability, and injury
(Mechanic, 2005; Mensah, Mokdad, Ford, Greenlund, & Croft, 2005).
Indeed, African American/Black individuals remain significantly and
consistently more at risk for early death than do similar non-Latinx
White individuals (Williams, Neighbors, & Jackson, 2003; Williams, Yu,
Jackson, & Anderson, 1997); overall early death rates of African

American/Black individuals are comparable to those observed among
non-Latinx Whites in the U.S. decades ago (Levine et al., 2016; Williams
& Jackson, 2005). Differences in prevalence and rate of growth of
chronic illness are not accounted for solely by exposure to lower income
environments (Franks, Muennig, Lubetkin, & Jia, 2006). Indeed, social
determinants of health (e.g., racism; Krieger & Sidney, 1996), addictive
behavior (e.g., tobacco use; Sakuma et al., 2015), and stress represent
robust and consistent factors related to health inequalities among
African American/Black individuals and those from other underrepresented racial/ethnic groups. The COVID-19 pandemic has appeared to strike racial and ethnic minority populations (e.g., African
American/Black) hard and with possible longer-term consequences. For
example, less access to health care services for chronic illness, addictive
behavior, and mental illness could exacerbate COVID-19 related
symptoms or promote a greater degree of stress-related burden associated with the pandemic (e.g., worry that loved ones, if infected,
cannot access care). Consequently, addictive behaviors (e.g., smoking,
alcohol misuse) and health behaviors (e.g., disrupted sleep, emotional
eating) may be used in the short-term to cope with such COVID-19
related stress, increasing the longer-term risk for more severe negative
emotional symptoms and health complaints (e.g., pain) and chronic
health problems (e.g., obesity).
Additionally, situations characterized by mass fear and confusion,
such as the current pandemic, also can elicit a human instinct to resolve
the confusion and mitigate the fear by identifying a culprit for the introduction or spread of the disease (Bard, Verger, & Hubert, 1997;
Bromet, 2011). Asian American persons are one group that has been
singled out as responsible for the COVID-19. The misdirection of fear
and/or anger related to COVID-19 toward a racial or ethnic group instead of the disease, however, can perpetuate fear and contribute to
racism and stigma. Several reports have already documented the rise in
violent crimes and discrimination experienced by Asian American
persons related to COVID-19 beliefs (E. Liu, 2020). COVID-19 specific
language, such as referring to COVID-19 as ‘the Chinese virus,’ has
created a platform to propagate stigma and discrimination towards
Asian Americans. It is likely that stigma and discrimination experienced
by Asian Americans in response to COVID-19 will increase emotional
distress, coping-oriented addictive behavior, and may alter health behavior or exacerbate chronic illness.
It would also be remiss to not call explicit attention to the fact that
societies marked by greater economic and social inequality experience
far more medical, psychological, and social pathology than do societies
where such wealth inequalities are less pronounced (Wilkinson &
Pickett, 2006, 2007). Further, such adverse effects occur across social
classes, not merely among the most disadvantaged. Yet, the adverse
effects of economic (and thus social) inequality hurt everyone, although
the poorest or most marginalized are affected the most (Pickett, Kelly,
Brunner, Lobstein, & Wilkinson, 2005; Wilkinson & Pickett, 2008).
5.2. Developmental considerations
There are far-reaching implications for psychological health, addictive behavior, and health behavior from a developmental perspective. For children, despite COVID-19 appearing to have less severe
symptoms and lower mortality rates than other age groups, are among
the highest risk groups (Sinha et al., 2020; Zimmermann & Curtis,
2020). Estimates suggests that there are over 1 billion children not in
school (Cluver et al., 2020). The economic impact of COVID-19 will
likely be related to greater risk for children to be utilized to offset such
financial hardship (e.g., selling merchandise on the street, forced begging for food and goods) and be a more likely to be abused (Campbell,
2020). For example, it is possible that children will be more likely to be
used for child labor and be exploited for sexual behavioral and experience corresponding risk for sexual disease and pregnancy as well as
serious psychological distress. Interpersonal violence and child abuse
will affect children at a significant rate, especially under conditions
9

Behaviour Research and Therapy 134 (2020) 103715

M.J. Zvolensky, et al.

wherein there is no oversight from educational systems due to quarantine. World health organizations are already predicting an increase in
children who will be orphaned and exposed to abuse and neglect
(Cluver et al., 2020). Child abuse is less likely to be detected during the
COVID-19 pandemic because the reduction or lack of child protection
agencies monitoring cases, and teachers less able to detect signs of
abuse. Further, children who received meals at school through government programs such as the National School Lunch Program may
now no longer have access to nutritious food, which can negatively
impact their development.
The lack of structure from schooling and missed education will have
a lasting impact on well-being and apt to be related to increased anxiety, depression, and stress about educational attainment and progress
going forward (Van Lancker & Parolin, 2020). Although on-line school
may help offset some of these challenges, disparities will exist for those
who are most vulnerable, including those who lack internet access or
cannot afford technology. Older children and young adults may be
more likely to drop out of school to help offset family needs. Children
and youth also may be engaging in more on-line behavior in general or
due to emotional distress (e.g., loneliness due to social isolation) and be
increasing the chance for solicitation from others who prey on their
emotional vulnerabilities (Peterman et al., 2020, p. 528). Lacking access to physical activity due to quarantine protocols may reduce fitness
levels and immunological response as well as decrease psychological
wellbeing (Rundle, Park, Herbstman, Kinsey, & Wang, 2020).
Children and youth in juvenile systems, such as orphanages, already
were exposed to high density living conditions and often lack access to
proper medical or psychological care. The COVID-19 pandemic is likely
to place pressure on such systems (e.g., more children) and the physical
environments of these settings may be amenable to the spread of infection. Likewise, refugee or otherwise displaced children and youth
often live-in high-density environments wherein social distancing is
challenging if not impossible. Further, lack of access in these settings to
cleaning supplies and water can catalyze the spread of COVID-19 or
even the basic fear of acquiring the virus. To the extent the COVID-19
challenges the medical system, it is possible other forms of medical care
necessary for child welfare (e.g., routine exams, immunizations) will be
reduced, as was the case during other pandemics such as Ebola
(Mupere, Kaducu, & Yoti, 2001). Collectively, COVID-19 places an enormous stress on children and youth, placing them at an increased risk
for psychological disturbances and physical health vulnerability (Liu,
Bao, Huang, Shi, & Lu, 2020).
COVID-19 also will affect ranges of the lifespan, including adults
and older adults. The well-publicized health risks for older adults place
an obvious psychological and health pressure on this group. Older
adults are among the most likely to have a chronic illness (e.g., diabetes, cancer, cardiovascular disease) and consequently they maintain
an increased vulnerability to deteriorating health and death from
COVID-19. However, even in the absence of exposure to the virus, the
fear and worry about contracting the disease is apt to be significant for
this group, especially when in homecare facilities such as nursing
homes or hospitals (Armitage & Nellums, 2020). This group also is at
significant risk for lacking transportation for food, which could challenge the quality of nutrition and have a negative effect in immunological function. Similarly, older adults are among the least physical active groups, which again, will have the potential for decreasing
psychological wellbeing and immunity.
Although not specific to older adults, the potential for disruption in
grief and loss of others also is a significant psychological stressor.
During the pandemic, regular methods of grieving such as funerals have
been limited if not all together impossible. The inability to grieve with
others or as traditionally done may spur escalation in psychological
distress (e.g., sadness, depression) and complicate the grief process
(Wallace, Wladkowski, Gibson, & White, 2020). To the extent that grief
is impaired, individuals may engage in maladaptive addictive behaviors
(e.g., alcohol misuse) to cope with the aversive experiences. Similar

types of emotional reactions may occur when parents are separated
from their children due to quarantine protocols and disruptions in
travel (e.g., cannot travel to see children located in another region).
5.3. Individual differences relevant to psychological dysfunction, addiction,
and health behavior
There are several individual difference factors at a psychological
level of analysis that will place people at an increased or decreased risk
for psychological problems, addiction, and poor health behavior, and
chronic illness during and after the pandemic. Research over the past
few decades has theorized and found consistent empirical support for
emotional symptoms and disorders as well as addictive behavior being
explained by individual differences in transdiagnostic processes (SauerZavala et al., 2012). Transdiagnostic factors may contribute to onset,
maintenance, and exacerbation of emotional symptomatology and addictive and health behavior. A core aspect of transdiagnostic models is
that they seek to identify basic processes underlying multiple, usually
comorbid, psychopathologies or addictive behavior.
One set of transdiagnostic factors relevant to COVID-19 may be
those that are “reactive” vulnerabilities; that is, individual differences
that reflect a heightened emotional response to stressful stimuli. Such
vulnerabilities influence emotion experience by enhancing or diminishing the normative response to emotion stimuli and states, resulting in
an excess or deficit, respectively, beyond typical emotional functioning;
or altering the type of response to emotion stimuli and states (Gratz &
Roemer, 2004; Reiss, 1991; Zvolensky, Bernstein, & Vujanovic, 2011).
In both instances, such reactive processes may be maladaptive because
they serve to reinforce the intensity and frequency of future emotional
symptoms. For example, when faced with negative emotion states, individuals with an emotional vulnerability factor that limits their capacity to handle distress may be more apt to execute behaviors that
preclude habituation to negative emotion states, which could ultimately
increase the intensity of future negative affect and solidify beliefs and
learned responses that interfere capacity to adaptively respond to distress.
To illustrate, a transdiagnostic factor that may be especially relevant
to COVID-19 related stress responsivity, substance use, and physical
health is anxiety sensitivity (Taylor, 2014). Anxiety sensitivity is a
malleable, cognitive-affective factor reflecting the tendency to respond
to interoceptive distress with anxiety (McNally, 1989). Anxiety sensitivity is related to, yet distinct from, negative affectivity and trait anxiety (Keough, Riccardi, Timpano, Mitchell, & Schmidt, 2010). Anxiety
sensitivity has demonstrated racial/ethnic, gender, age, and time invariance (Ebesutani, McLeish, Luberto, Young, & Maack, 2014; Farris
et al., 2015; Jardin et al., 2018). Given COVID-19 can produce physical
sensations and even when not infected, COVID-related stress can elicit a
range of interoceptive sensations, persons higher in anxiety sensitivity
may be more be emotional reactive to such stimuli and engage in behavior to dampen stress symptoms (e.g., using tobacco, alcohol). For
example, persons may interpret the onset of aversive bodily sensations
(e.g., runny nose, cough, fever) as intolerable or catastrophic, exacerbating the experience of such interoceptive symptoms. Further, interoceptive symptoms might be particularly salient to persons with higher
anxiety sensitivity who are prone to health inequalities (e.g., racial/
ethnic minorities, persons in financial stress), as they may be more apt
to perceive these internal sensations as uncontrollable because resources to regulate symptoms (i.e., adaptive cognitive and behavioral
skills) are likely diminished due to chronic stress exposure (e.g., low
socioeconomic status, discrimination). In turn, persons higher in anxiety sensitivity may be motivated to use substances to reduce emotional and interoceptive distress, elevating their chance for physical
illness and compromised immune system function. Although this illustrative example represents only one of many possible transdiagnostic
amplifying factors, it draws attention to the fact that individual differences in psychological processes are apt to play a central role in the
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relation between COVID-19 related stress and mental health, addictive
behavior, health behavior, and chronic illness.
Individual difference factors also may play roles in offering resilience to COVID-19 related stress. That is, individual differences may
contribute to the likelihood of a resilient response to COVID-19 in the
short and long term. Thus, in addition to the many situational and
contextual factors, individual difference factors will likely shape the
level of resiliency to COVID-19 pandemic. Here, it is likely individual
difference factors that de-amplify stress responses will play a central
role in offsetting relative risk for psychological, addictive, and health
behaviors problems and exacerbation of chronic illness (Pidgeon &
Keye, 2014). As with affect amplifying factors, such as anxiety sensitivity, there most certainly is a range of factors of potential importance,
including flexible coping repertoires, mindfulness, self-efficacy, selfcompassion, and proneness to experience positive affect. To illustrate,
individual difference in the capacity to accept difficult COVID-19 related stress may offset the potential escalation of anxiety, stress, and
depression and mitigate the need for addictive or unhealthy behaviors
(e.g., emotional eating) to delimit aversive internal experiences
(Ranzijn & Luszcz, 1999). Consequently, the corresponding risk for
health complaints or worsening of chronic health conditions can be
offset. Indeed, there is a large theoretical and empirical literature that
suggests the capacity to accept difficult emotions experiences is related
to psychological well-being and adaptation. For example, one of the
reasons meditative practice is related to decreased stress is via change
emotional acceptance (Teasdale et al., 2002). This type of work has
robust implications in efforts to intervene on COVID-19 related stress in
the immediate context and for those that struggle to regain stability and
growth in the future in terms of mental health, addictive behavior, and
health behavior.

reciprocal and dynamic.
Although the model offered here is purposively general and is offered only as a heuristic, it is presumed that there is, in fact, specificity
between specific affect amplifying and de-amplifying factors, moderators, mediators, and various forms of psychological and chronic illness. That is, a specific type of individual difference factor like anxiety
sensitivity is linked to a particular type of problem (e.g., anxiety disorder, worsening of a chronic respiratory illness, severity of hazardous
drinking) via a specified mediating process (e.g., smoking, sleep disruption) in the context of certain moderating variables (e.g., higher
levels of COVID-19 stress burden). The core idea being that the underlying mechanism in this hypothetical example may be quite different
from that explaining other problems.
The above theoretical model requires empirical testing, and if it is
confirmed, one next logical step would be to intervene in it to reduce
the burden of mental health, addictive disorders, poor health behaviours, and chronic health conditions related to COVID-19 stress
burden. Ideally, this type of intervention approach would target the
root of the pathway, including affect amplifying (i.e., decreasing levels)
and de-amplifying (i.e., promoting growth). However, intervention efforts sit in the fact that the healthcare system will continue to shift and
adapt to treatment delivery, including the uptake of digital health
technologies. Digital health, including mobile health (mHealth), telemedicine/telehealth, and health information technology (e.g., mobile
phones, wearable sensors), can be used to develop scalable interventions to promote adherence public health guidelines for mitigating the
spread of COVID-19. They also can be combined with greater attention
to affect amplifying (i.e., decreasing levels) and de-amplifying (i.e.,
promoting growth) factors that govern many psychological, addictive,
and health behaviour processes. Here, there is great opportunity for
growth of digital health interventions to offer standalone clinical grade
therapeutic tactics and as an adjunct to face-to-face interventions. This
type of work can close the gap in access to care and offer evidencebased interventions to large segment of society. For example, digital
interventions can be used to combat resistance to public health measures at the level of individuals and institutions with a consideration of
individual difference factors that affect emotional and behavioral selfregulation. Indeed, the public's response to public health measures is
itself a potential risk and protective factor for many of the psychological, addictive, and health behavior problems reviewed in this essay.

5.3.1. Theoretical model of COVID-19 stress burden
Despite the present lack of systematic empirical work on COVID-19
in terms of behavioral health problems, there is good theoretical basis
from past scientific work to hypothesize that COVID-19 related stress
burden, due to a myriad of sources, may play a major vulnerability role
in terms of mental health, addictive disorders, and health behaviors as
well as chronic illness. For some, the stress-related burden of COVID-19
may elicit fundamental changes in risk potential and serve as a fertile
basis for future behavioral health problems. For others, the ability to
adapt to COVD-19 will offer a different course; one that is characterized
by greater stability, speed of recovery, and growth. Further, it is important to recognize that the adaptation process to COVID-19 related
stress is apt to be non-linear in many instances. That is, contextual
factors (e.g., future life stressors, access to social support) can influence
the degree of risk for future problems.
Research described in this essay provides a basis to develop a theoretical model that could be used to evaluate COVID-19 related stress
burden on psychological, addictive, and health behaviour problems. We
therefore begin this section by briefly outlining a general model that
can be used as a heuristic for understanding the complex issues at hand.
See Fig. 1 for a graphical depiction of the model. In general, we predict
individual differences in affect amplifying and de-amplifying factors
will predict the course of psychological, addictive behavior and health
behavior and chronic illness even when considering differences in exposure to COVID-19 experiences (e.g., time of quarantine, acquisition of
virus). We would predict, based on past work that transdiagnostic affect
amplifying factors will influence addictive and health behaviour, which
in turn, will increase (or decrease if de-amplifying) the risk of chronic
illness and psychological problems and their comorbidity. Further, we
can expect that this type of perspective will be moderated by daily
stress in the future and access to stress-dampening resources (e.g., social support). Accordingly, certain subgroups more prone to greater and
more chronic stress, such as first responders and racial/ethnic minorities and orphaned children, may be particularly vulnerable. This
conceptual model predicts that the associations which exist between are

6. Conclusion
The public health impact of COVID-19 on psychological symptoms
and disorders, addiction, and health behavior is substantial and ongoing. There is a need for financial and social investment in research to
better understand how COVID-19 affects the onset, maintenance, and
relapse potential for some of the most common, costly, and chronic
behavioral health conditions in the general population. Further, there is
a need for the study of the role of psychological processes, addictive
behavior, and health behavior in terms of the onset and maintenance of
COVID-19 infection and stress burden. There most certainly will be a
demand for preventative and intervention efforts for managing the
impact of COVID-19 among individuals with elevated negative mood
symptoms and disorders, addictive behavior, and certain health behaviors (e.g., sleep disorders) and chronic illness. This work is important
to offset the current and projected burden to personal, system, and
societal entities, and for providing a theoretical and empirical knowledge base for future pandemics. We presented a heuristic model, which
posits that COVID-19 related stress and mood, addictive, and health
behavior may, in fact, exacerbate each other via several distinct mechanisms. Future research in this emerging area has the potential to
refine both theory and application with respect to COVID-19 and its
relation to affect, addiction, and health behavior as well as chronic
disease.
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Fig. 1. Theoretical Model for how COVID-19 stress burden may be associated with addictive problems and health behaviors, and how these may be associated with
later chronic illness and psychological problems.
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